Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. L-isomer Methionine
2. L-methionine
3. Liquimeth
4. Methionine
5. Methionine, L Isomer
6. Methionine, L-isomer
7. Pedameth
1. 59-51-8
2. Methionine
3. Racemethionine
4. Acimetion
5. Lobamine
6. Banthionine
7. Cynaron
8. Meonine
9. Mertionin
10. Metione
11. Pedameth
12. Urimeth
13. Dyprin
14. Neston
15. H-dl-met-oh
16. (+-)-methionine
17. Dl-methioninum
18. Dl-2-amino-4-(methylthio)butanoic Acid
19. D,l-methionine
20. Methionine, Dl-
21. Fema No. 3301
22. 2-amino-4-methylsulfanylbutanoic Acid
23. Methionine Dl-form
24. 2-amino-4-(methylsulfanyl)butanoic Acid
25. 2-amino-4-(methylthio)butyric Acid
26. 2-amino-4-(methylthio)butanoic Acid
27. Methilonin
28. Racemethionine [usan]
29. Dl-2-amino-4-(methylthio)-butyric Acid
30. Alpha-amino-gamma-methylmercaptobutyric Acid
31. Nsc 9241
32. Mfcd00063096
33. Alpha-amino-gamma-(methylthio)butyric Acid
34. Nsc-9241
35. (+/-)-2-amino-4-(methylmercapto)butyric Acid
36. Dl-2-amino-4-(methylthio)butyric Acid
37. 73jwt2k6t3
38. Dl-methionine (racemethionine)
39. Chebi:16811
40. 2-amino-4-methylthiobutanoic Acid
41. Poly-l-methionine
42. Nsc22946
43. 26062-47-5
44. 2-amino-4-(methylmercapto)butyric Acid
45. Ncgc00159431-02
46. Dl-methionine (jan)
47. Racemethionine (usan)
48. .alpha.-amino-.gamma.-methylmercaptobutyric Acid
49. Dl-methionine [jan]
50. R-methionine
51. Methionine, Amorphous
52. Methionine Dl-
53. Ccris 3717
54. (+/-)-methionine
55. Einecs 200-432-1
56. Unii-73jwt2k6t3
57. Petameth
58. Amurex
59. Metion
60. Dl-methionin
61. Hmet
62. Ai3-18475
63. Mfcd00002622
64. Nsc-45689
65. Racemethionine [usan:usp:nf]
66. Dl-methionine;
67. Padameth (tn)
68. Alpha-amino-gamma-methylmercaptobutyric Acid (van)
69. Dl-met
70. Dl-2-amino-4-methylthiobutanoic Acid
71. ((c)i)-methionine
72. Racemethionine, Usan
73. 2-amino-4-methylsulfanyl-butanoic Acid
74. 7005-18-7
75. Dextro,laevo-methionine
76. Methionine,l-
77. 2-amino-4-(methylthio)-butyric Acid
78. (.+-.)-methionine
79. Dsstox_cid_821
80. (.+/-.)-methionine
81. Met248
82. Dl-methionine, >=99%
83. Schembl4225
84. Dl-methionine [fcc]
85. Dsstox_rid_75809
86. Wln: Qvyz2s1 -l
87. Dsstox_gsid_20821
88. D,l-methionine [fhfi]
89. Dl-methionine [mart.]
90. Chembl274119
91. Dl-methionine [who-dd]
92. Dl-methionine [who-ip]
93. H3csch2ch2ch(nh2)cooh
94. Racemethionine [usp-rs]
95. Dtxsid9020821
96. Methionine Dl-form [mi]
97. Bdbm86195
98. Fema 3301
99. Nsc9241
100. Dl-ch3sch2ch2ch(nh2)cooh
101. Dl-methionine, 99%, Fcc, Fg
102. Cas_6137
103. Dl-methionine [ep Impurity]
104. Hy-n0325
105. Nsc_6137
106. Nsc45689
107. Tox21_111663
108. Bbl009323
109. Cas_84815
110. Dl-methionine [ep Monograph]
111. Dl-methionine, >=99.0% (nt)
112. Nsc_84815
113. Nsc118113
114. Nsc522406
115. S9344
116. Stk802463
117. 2-amino-4-(methylthio) Butyric Acid
118. 2-amino-4-methylsulfanyl-butyric Acid
119. Akos000118924
120. Akos016050523
121. Dl-methioninum [who-ip Latin]
122. Ccg-266195
123. Db13972
124. Nsc-118113
125. Nsc-522406
126. Cas-59-51-8
127. Butyric Acid, 2-amino-4-(methylthio)-
128. Ncgc00159431-03
129. Ncgc00159431-04
130. Ds-16180
131. Sy004418
132. L(-)-amino-.gamma.-methylthiobutyric Acid
133. Db-029693
134. .gamma.-methylthio-.alpha.-aminobutyric Acid
135. Am20100433
136. Cs-0008889
137. Ft-0625489
138. Ft-0625547
139. Ft-0671134
140. Ft-0690213
141. Ft-0693483
142. Ft-0698675
143. Ft-0699633
144. Ft-0771524
145. M0463
146. C01733
147. D04983
148. D72471
149. Dl-methionine, Saj Special Grade, >=99.0%
150. Dl-methionine, Vetec(tm) Reagent Grade, 98%
151. L-.gamma.-methylthio-.alpha.-aminobutyric Acid
152. Z00115
153. Ab00373904-02
154. 063m096
155. Q180341
156. Sr-01000944495
157. J-300193
158. L-.alpha.-amino-.gamma.-methylmercaptobutyric Acid
159. Q-201029
160. Sr-01000944495-1
161. Z57127440
162. F0001-1544
163. C6115881-e914-4ea8-a21a-dcbf67783824
164. Dl-methionine, European Pharmacopoeia (ep) Reference Standard
165. Racemethionine, United States Pharmacopeia (usp) Reference Standard
166. 33807-07-7
167. Dl-methionine, Bioreagent, Suitable For Cell Culture, Suitable For Insect Cell Culture, >=99%
| Molecular Weight | 149.21 g/mol |
|---|---|
| Molecular Formula | C5H11NO2S |
| XLogP3 | -1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 149.05104977 g/mol |
| Monoisotopic Mass | 149.05104977 g/mol |
| Topological Polar Surface Area | 88.6 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 97 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AB - Antidotes
V03AB26 - Methionine
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kewpie Corporation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Granulation
Thickeners and Stabilizers
Lubricants & Glidants
Parenteral
Co-Processed Excipients
Emulsifying Agents
Disintegrants & Superdisintegrants
Taste Masking
Topical
Controlled & Modified Release
Coating Systems & Additives
Chewable & Orodispersible Aids
Film Formers & Plasticizers
Solubilizers
API Stability Enhancers
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Methionine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methionine manufacturer or Methionine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methionine manufacturer or Methionine supplier.
PharmaCompass also assists you with knowing the Methionine API Price utilized in the formulation of products. Methionine API Price is not always fixed or binding as the Methionine Price is obtained through a variety of data sources. The Methionine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-amino-4-(methylsulfanyl)butanoic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-amino-4-(methylsulfanyl)butanoic acid, including repackagers and relabelers. The FDA regulates 2-amino-4-(methylsulfanyl)butanoic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-amino-4-(methylsulfanyl)butanoic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2-amino-4-(methylsulfanyl)butanoic acid supplier is an individual or a company that provides 2-amino-4-(methylsulfanyl)butanoic acid active pharmaceutical ingredient (API) or 2-amino-4-(methylsulfanyl)butanoic acid finished formulations upon request. The 2-amino-4-(methylsulfanyl)butanoic acid suppliers may include 2-amino-4-(methylsulfanyl)butanoic acid API manufacturers, exporters, distributors and traders.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 2-amino-4-(methylsulfanyl)butanoic acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 2-amino-4-(methylsulfanyl)butanoic acid active pharmaceutical ingredient (API) in detail. Different forms of 2-amino-4-(methylsulfanyl)butanoic acid DMFs exist exist since differing nations have different regulations, such as 2-amino-4-(methylsulfanyl)butanoic acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 2-amino-4-(methylsulfanyl)butanoic acid DMF submitted to regulatory agencies in the US is known as a USDMF. 2-amino-4-(methylsulfanyl)butanoic acid USDMF includes data on 2-amino-4-(methylsulfanyl)butanoic acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 2-amino-4-(methylsulfanyl)butanoic acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 2-amino-4-(methylsulfanyl)butanoic acid Drug Master File in Japan (2-amino-4-(methylsulfanyl)butanoic acid JDMF) empowers 2-amino-4-(methylsulfanyl)butanoic acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 2-amino-4-(methylsulfanyl)butanoic acid JDMF during the approval evaluation for pharmaceutical products. At the time of 2-amino-4-(methylsulfanyl)butanoic acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid suppliers with JDMF on PharmaCompass.
A 2-amino-4-(methylsulfanyl)butanoic acid CEP of the European Pharmacopoeia monograph is often referred to as a 2-amino-4-(methylsulfanyl)butanoic acid Certificate of Suitability (COS). The purpose of a 2-amino-4-(methylsulfanyl)butanoic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 2-amino-4-(methylsulfanyl)butanoic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 2-amino-4-(methylsulfanyl)butanoic acid to their clients by showing that a 2-amino-4-(methylsulfanyl)butanoic acid CEP has been issued for it. The manufacturer submits a 2-amino-4-(methylsulfanyl)butanoic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a 2-amino-4-(methylsulfanyl)butanoic acid CEP holder for the record. Additionally, the data presented in the 2-amino-4-(methylsulfanyl)butanoic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 2-amino-4-(methylsulfanyl)butanoic acid DMF.
A 2-amino-4-(methylsulfanyl)butanoic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 2-amino-4-(methylsulfanyl)butanoic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 2-amino-4-(methylsulfanyl)butanoic acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 2-amino-4-(methylsulfanyl)butanoic acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 2-amino-4-(methylsulfanyl)butanoic acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 2-amino-4-(methylsulfanyl)butanoic acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 2-amino-4-(methylsulfanyl)butanoic acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 2-amino-4-(methylsulfanyl)butanoic acid suppliers with NDC on PharmaCompass.
2-amino-4-(methylsulfanyl)butanoic acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2-amino-4-(methylsulfanyl)butanoic acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2-amino-4-(methylsulfanyl)butanoic acid GMP manufacturer or 2-amino-4-(methylsulfanyl)butanoic acid GMP API supplier for your needs.
A 2-amino-4-(methylsulfanyl)butanoic acid CoA (Certificate of Analysis) is a formal document that attests to 2-amino-4-(methylsulfanyl)butanoic acid's compliance with 2-amino-4-(methylsulfanyl)butanoic acid specifications and serves as a tool for batch-level quality control.
2-amino-4-(methylsulfanyl)butanoic acid CoA mostly includes findings from lab analyses of a specific batch. For each 2-amino-4-(methylsulfanyl)butanoic acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2-amino-4-(methylsulfanyl)butanoic acid may be tested according to a variety of international standards, such as European Pharmacopoeia (2-amino-4-(methylsulfanyl)butanoic acid EP), 2-amino-4-(methylsulfanyl)butanoic acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2-amino-4-(methylsulfanyl)butanoic acid USP).
